Kumukūʻai Medroxyprogesterone Acetate CAS 71-58-9
Wehewehe Huahana
ʻO Medroxyprogesterone Acetate, i ʻike ʻia hoʻi ʻo Medroxyprogesterone 17-acetate a i ʻole MPA, he progestogen synthetic a he progestin steroidal. Loaʻa ia mai ka hormone progesterone kanaka. Kāohi ia i ka fertilization a hoʻonui i ka wikiwiki o ka lawe ʻana o nā hua manu mai nā ʻōpū fallopian i ka uterus i loko o nā ferrets wahine ke lawelawe ʻia ma mua o ka ovulation. Hoʻopaʻa hou ʻo Medroxyprogesterone 17-acetate i ka ovulation i loko o nā ʻiole ke hoʻokomo ʻia i ka lā hope o ka diestrus. Loaʻa iā ia ka hana anti-androgenic i loko o nā ʻiole, e hoʻemi ana i nā pae testosterone plasma ma o ka hoʻoulu ʻana o ka hana testosterone reductase hepatic. Hōʻike ʻo Medroxyprogesterone 17-acetate i nā hopena immunosuppressive i loko o vitro a me in vivo, e kāohi ana i ka hana ʻana o IFN-γ e nā CD2/CD3/CD28-stimulated peripheral blood mononuclear cells (PBMCs) ma nā ʻano ≥10 nM a hoʻolōʻihi i ke ola o nā allografts ʻili rabbit. Ua hoʻohana ʻia nā ʻano injectable e loaʻa ana ka medroxyprogesterone 17-acetate ma ke ʻano he contraception.
Hoʻohuihui
Noi
ʻO ka Medroxyprogesterone Acetate kahi agonist receptor progesterone synthetic i hoʻohana ʻia e mālama i ka amenorrhea (ka pau ʻana o ka menstrual) a me ke kahe koko ʻana o ka ʻōpū ma ke ʻano ʻē.
Progestogen:
ʻO Cachexia (laikini ʻole ʻia), pale ʻana i ka hāpai ʻana, maʻi epilepsy, moekolohe kāne, nā neoplasms malignant, nā maʻi hanu, ka maʻi sickle-cell, ke kahe koko ʻana o ka uterine, endometriosis.
Hoʻopili a me ka mālama ʻana
Hoʻopili ʻia: 1 kg/ʻōmole a i ʻole 25 kg/pahu a i ʻole ma muli o nā koi a ka mea kūʻai aku.
Ka mālama ʻana: E mālama i kahi ʻokoʻa, anuanu, maloʻo a hoʻoulu maikaʻi ʻia ka ea, a pale pono i ka makū.
Nā kikoʻī
E ʻoluʻolu e leka uila e kiʻi i ka COA a me MSDS.
